• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD have to make a difficult choice about whether to continue or stop taking ADHD medication during pregnancy and breastfeeding. There are few data on how exposure to adhd and depression medication for a long time could affect a fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological issues like hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality research.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication must consider the benefits of taking it against the possible risks for the baby. Physicians don't have the data to make unambiguous recommendations, but can provide information on the risks and benefits to aid pregnant women in making informed choices.

A study published in Molecular Psychiatry found that women who used ADHD medications during their early pregnancy did not face a significantly increased risk of fetal heart malformations or major birth defects that are structural. Researchers conducted a large sample-based case control study to assess the frequency of structural defects that were major in infants who were born to mothers who took stimulants during pregnancy. Clinical geneticists and pediatric cardiologists reviewed the cases to ensure an accurate case classification and to minimize the possibility of bias.

However, the study had its limitations. The most important issue was that they were not able to differentiate the effects of the medication from the effects of the disorder at hand. This limitation makes it difficult for researchers to determine if the small associations observed among the groups that were exposed to the use of medications or caused by co-morbidities. The researchers also did not study long-term outcomes for offspring.

The study showed that babies whose mothers took ADHD medication during pregnancy were at a slightly higher chance of being admitted to the neonatal care unit (NICU), compared to mothers who did not use any medication during pregnancy or had quit taking the medication prior to or during pregnancy. This increase was due to central nervous system-related disorders, and the increased risk for admission did not appear to be influenced by the stimulant medications were used during pregnancy.

Women who took stimulant ADHD medication during pregnancy also had an elevated chance of having a caesarean delivery or having a baby with a low Apgar score (less than 7). These increases did appear to be unrelated to the type of medication taken during pregnancy.

Researchers suggest that the small risks posed by the use of ADHD medications in early pregnancies could be offset by the more beneficial outcomes for both mother and baby of continuing treatment for the woman's condition. Physicians should discuss the issue with their patients and, where they are able, assist them in developing strategies for improving their coping skills that may minimize the effects of her disorder on her daily functioning and relationships.

Medication Interactions

As more women than ever are diagnosed with ADHD and being treated with medication, the dilemma of whether to keep or discontinue treatment during pregnancy is one that more and more physicians confront. These decisions are frequently made without clear and authoritative evidence. Instead, physicians must consider their own expertise in conjunction with the experiences of other Doctors prescribing adhd medication and the research on the topic.

Particularly, the subject of potential risks for the infant can be difficult. Many studies on this subject are based on observational evidence instead of controlled research and their conclusions are often contradictory. In addition, most studies limit their analysis to live births, which may underestimate the severity of teratogenic effects that could lead to abortion or termination of the pregnancy. The study that is discussed in the journal club addresses these shortcomings, by examining both the data from deceased and live births.

Conclusion Some studies have found a positive correlation between ADHD medications and certain birth defects However, other studies haven't shown such a relationship. Most studies have shown an unintended, or somewhat negative, effect. In every case, a careful study of the risks and benefits must be performed.

For many women with ADHD, the decision to stop taking medication can be difficult, if not impossible. In an article published in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of loneliness and family conflict for those suffering from the disorder. A decrease in medication could affect the ability to safely drive and to perform work-related tasks which are crucial aspects of daily life for people with ADHD.

She recommends that women who are unsure about whether or not to discontinue medication due to their pregnancy consider educating family members, friends, and coworkers on the condition, its impact on daily life, and the advantages of staying on the current treatment regimen. It can also help a woman feel confident about her decision. It is important to remember that certain medications can pass through the placenta, so if the patient decides to discontinue her inattentive adhd medication medication during pregnancy and breastfeeding, she must be aware that traces of the drug can be transferred to the child.

Birth Defects and Risk of

As the use and abuse of ADHD medications to treat the symptoms of attention deficit disorder hyperactivity disorder (ADHD), increases as does the concern about the potential effects of these drugs on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this issue. Utilizing two huge data sets researchers were able to analyze more than 4.3 million pregnancies to determine whether stimulant medications increased the risk of birth defects. Although the risk overall remains low, the scientists did find that first-trimester exposure to ADHD medications was associated with an increase in the risk of certain heart defects such as ventriculoseptal defect (VSD).

The researchers of the study found no association between early use of medication and other congenital abnormalities, such as facial clefting or club foot. The results are in line with previous studies that have shown a small but significant increase in the risk of developing cardiac malformations among women who began taking ADHD medications prior to the time of pregnancy. This risk increased in the latter half of pregnancy, as many women begin to discontinue their ADHD medications.

Women who were taking ADHD medication in the first trimester were more likely to need a caesarean, have a low Apgar after birth and had a baby that required breathing assistance at birth. The authors of the study were not able to eliminate selection bias because they limited their study to women without other medical conditions that could have contributed to the findings.

Researchers hope that their research will inform physicians when they see pregnant women. They suggest that although a discussion of the risks and benefits is crucial however, the decision to stop or keep medication should be based on each woman's requirements and the severity of her ADHD symptoms.

The authors warn that, even though stopping the medication is a possibility to look into, it is not recommended due to the high rate depression and other mental problems among women who are pregnant or recently gave birth. Research has also shown that women who stop taking their medication will have a difficult adjustment to life without them after the baby is born.

Nursing

It can be overwhelming to become a mom. Women who suffer from ADHD who must work through their symptoms while attending doctor appointments as well as getting ready for the arrival of a baby and adapting to new routines in the home may face a lot of challenges. Many women opt to continue taking their ADHD medication during pregnancy.

The majority of stimulant drugs pass through breast milk in very small quantities, so the risk for breastfeeding infant is minimal. However, the rate of medication exposure to the newborn may differ based on dosage, how often it is administered, and the time of day it is administered. Additionally, different medications are introduced into the baby's system through the gastrointestinal tract, or through breast milk. The impact on the health of a newborn isn't completely understood.

Because of the lack of research, some doctors might be tempted to stop taking stimulant drugs during a woman's pregnancy. This is a difficult decision for the woman who must weigh the advantages of her medication against the potential risks to the foetus. In the meantime, until more information is available, doctors may ask pregnant patients if they have a history of ADHD or if they plan to take medication in the perinatal period.

A growing number of studies have revealed that most women can safely continue taking their ADHD medication during pregnancy and while breastfeeding. In response, a rising number of patients are choosing to continue their medication. They have found, in consultation with their doctors that the benefits of keeping their current medication far outweigh any possible risks.

It is essential for women with ADHD who are thinking of breastfeeding to seek a specialist psychiatrist's guidance prior to becoming pregnant. They should review their medications with their prescriber and discuss the advantages and disadvantages of continuing treatment, including best non stimulant adhd medication for adults-pharmacological strategies. Psychoeducation is also needed to help pregnant women suffering from ADHD recognize the signs and the underlying disorder. They should also be educated about treatment options and build strategies for coping. This should be an approach that is multidisciplinary, including the GP as well as obstetricians, psychiatry and obstetricians. Counselling for pregnancy should include discussion of a management plan for both the mother as well as the child, as well as monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.